Primary Varicella in an Adult Patient With Diabetes
Abigail Hendrie1, Anh Hoang2, Jared Marshall2
1David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.
Abstract:
Although the introduction of the varicella vaccine has significantly reduced the incidence of primary varicella in adults, individuals with compromised immune systems, such as those with diabetes mellitus, remain at heightened risk for severe disease. We report the case of a 44-year-old male with a history of diabetes mellitus who presented to the emergency department with a diffuse, generalized rash associated with pruritus, burning sensation, and numbness and tingling. A polymorphic rash diffusely involving the face, trunk, extremities, scalp and palms emerged, beginning with erythematous macules and sequentially developing into papules, vesicles, and crusted lesions. A clinical diagnosis of primary varicella was made based on the characteristic rash and the patient's immunocompromised status, which was confirmed with antibody testing. He was treated with valacyclovir, corticosteroids, multimodal pain control, and antihistamines. This case highlights the continued risk of primary varicella in adults and the importance of considering it within the differential diagnosis, particularly in patients with immune dysfunction.
More Related Videos
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...


